G. Cooke

发表

Effect of platelet antigen polymorphism on platelet inhibition by aspirin, clopidogrel, or their combination.

P. Binkley, M. Moeschberger, R. Magorien, 2006, Journal of the American College of Cardiology.

A polymorphism of the gene encoding AMPD1: clinical impact and proposed mechanisms in congestive heart failure.

P. Binkley, A. Auseon, G. Cooke, 2004, Congestive heart failure.

Stem cell-derived cardiomyocytes demonstrate arrhythmic potential.

P. Binkley, S. Raman, G. Cooke, 2003, Circulation.

Platelet PlA2 Polymorphism and Thromboembolic Events: From Inherited Risk to Pharmacogenetics

P. Goldschmidt-Clermont, C. Roos, G. Cooke, 1999, Journal of Thrombosis and Thrombolysis.

The PlA polymorphism of glycoprotein IIIa functions as a modifier for the effect of estrogen on platelet aggregation.

P. Bray, P. Goldschmidt-Clermont, C. Roos, 2001, Archives of pathology & laboratory medicine.

PlA2, a variant of GPIIIa implicated in coronary thromboembolic complications.

P. Binkley, P. Goldschmidt-Clermont, G. Eaton, 2000, Journal of the American College of Cardiology.

Higher prevalence of GPIIIa PlA2 polymorphism in siblings of patients with premature coronary heart disease.

L. Becker, D. Becker, R. Blumenthal, 1999, Archives of pathology & laboratory medicine.

PlA2 polymorphism and efficacy of aspirin

P. Bray, P. Goldschmidt-Clermont, G. Cooke, 1998, The Lancet.

Post-menopausal hormone therapy and cardiovascular events: a new paradigm based on pharmacogenetics?

G. Cooke, 2008, Future cardiology.

Intronic polymorphism in CYP3A4 affects hepatic expression and response to statin drugs

W. Sadee, S. Wrighton, Danxin Wang, 2011, The Pharmacogenomics Journal.

Cardiovascular safety in patients receiving roflumilast for the treatment of COPD.

P. Calverley, P. Kowey, K. Rabe, 2013, Chest.

Evidence for the Role of Epstein Barr Virus Infections in the Pathogenesis of Acute Coronary Events

P. Binkley, R. Glaser, D. Knight, 2013, PloS one.

The results of this analysis also suggest the potential benefit of roflumilast on CV outcomes. Potential CV benefits of roflumilast should be evaluated in future controlled clinical trials.

P. Calverley, P. Kowey, K. Rabe, 2013 .

Detection of coronary artery disease in orthotopic heart transplant recipients with 64-detector row computed tomography angiography.

S. Iyengar, S. Raman, D. Feldman, 2006, The Journal of Heart and Lung Transplantation.

Plasma atherogenic markers in congestive heart failure and posttransplant (heart) patients.

P. Binkley, M. Moeschberger, C. Leier, 2000, Journal of the American College of Cardiology.

Estradiol increases platelet aggregation in Pl(A1/A1) individuals.

P. Goldschmidt-Clermont, K. Boudoulas, Christine R Montague, 2006, American heart journal.

Endothelial nitric oxide synthase polymorphisms associated with abnormal nitric oxide production are not over-represented in children with Down syndrome.

J. Hayes, C. Cua, G. Cooke, 2006, Congenital heart disease.

Priming of Platelet αIIbβ3 by Oxidants Is Associated With Tyrosine Phosphorylation of β3

K. Irani, P. Bray, P. Goldschmidt-Clermont, 1998 .

A meta‐analysis of studies on the association of the platelet PlA polymorphism of glycoprotein IIIa and risk of coronary heart disease

Hani Doss, Deborah Burr, Pascal J Goldschmidt-Clermont, 2003, Statistics in medicine.

HIV-1 infection and AIDS dementia are influenced by a mutant MCP-1 allele linked to increased monocyte infiltration of tissues and MCP-1 levels

B. Rovin, M. Bamshad, S. Mummidi, 2002, Proceedings of the National Academy of Sciences of the United States of America.

Single nucleotide polymorphism genotyping using allele-specific PCR and fluorescence melting curves.

W. Sadee, A. Papp, J. Pinsonneault, 2003, BioTechniques.

The safety and efficacy of aspirin and clopidogrel as a combination treatment in patients with coronary heart disease

P. Goldschmidt-Clermont, G. Cooke, 2006, Expert opinion on drug safety.

Endothelial nitric oxide synthase gene: prospects for treatment of heart disease.

Amit A. Doshi, P. Binkley, G. Cooke, 2007, Pharmacogenomics.

Recovery of normal ventricular function in patients with dilated cardiomyopathy: predictors of an increasingly prevalent clinical event.

P. Binkley, C. Leier, Laura M Yamokoski, 2008, American heart journal.

Pharmacogenetics of multigenic disease: heart disease as an example.

G. Cooke, 2006, Vascular pharmacology.

A polymorphism of the endothelial nitric oxide synthase promoter is associated with an increase in autonomic imbalance in patients with congestive heart failure.

P. Binkley, G. Cooke, Yiwen Liu-Stratton, 2005, American heart journal.

Evidence that human cardiac myocytes divide after myocardial infarction.

P. Binkley, G. Cooke, S. Raman, 2001, The New England journal of medicine.

Potential thrombophilic mutations/polymorphisms in patients with no flow-limiting stenosis after myocardial infarction.

H. White, P. Browett, P. Goldschmidt-Clermont, 2003, American heart journal.